Bodal Chemicals reported Q4 FY26 consolidated revenue of ₹5,906 mn, a 30.3% YoY growth, with PAT surging 121% to ₹320.6 mn.
FY26 consolidated revenue reached ₹20,539 mn, up 16.9% YoY, driven by volume growth, better realizations, and a SGST incentive.
The Basic Chemicals segment saw explosive growth of 239% YoY in Q4, while the new Saykha plant margins remained under pressure.
Management highlighted ongoing rationalization of non-core assets to maintain cash flow and expects gradual improvement from Saykha operations.